Risk Assessment, Genetics, Management of High Risk Patients Cases - Livestream Interactive Case Discussions for Session 3 & 4 - June 4, 2022

June 4, 2022

Livestream interactive case discussions for session 3 & 4

Learning Objectives

Upon conclusion of this activity, participants should be able to

  • Develop a consistent and comprehensive approach to identification of those at hereditary cancer with knowledge of NCCN guidelines, American Society of Breast Surgeons’ guidelines and those of USPSTF. 
  • Perform risk modeling in those without hereditary predisposition and understand the strengths and limitations of the various risk models (Gail – BCRAT, Tyrer-Cuzick, and BOADICEA/CanRisk)
  • Appreciate the role that single nucleotide polymorphisms (SNPs) and the polygenic risk score (PRS) will play in breast cancer risk assessment, sub-stratification of gene carriers, estimation of contralateral risk in the newly diagnosed and identification of lower risk individuals. 
  • Discuss the management of patients with biopsy-proven high-risk breast lesions, a strong family history of breast cancer, or identified gene mutations that significantly increase risk of breast cancer.
  • Understand the role of enhanced screening and surveillance imaging, and genetic testing.
  • Develop an approach to breast cancer risk mitigation strategies including lifestyle modifications, risk-reducing pharmacotherapy, or preventative surgery.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 2.75 AAFP Prescribed
  • 2.75 AMA PRA Category 1 Credit
  • 2.75 ANCC
  • 2.75 Attendance
Event starts: 
06/04/2022 - 9:00am
Event ends: 
06/04/2022 - 12:00pm
Cost:
$240.00
Internet Live Activity
United States

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this other activity (livestream and online content) for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP
The AAFP has reviewed Medical Breast Training Program, and deemed it acceptable for AAFP credit. Term of approval is from 04/01/2022 to 04/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This session Risk Assessment/Genetics Case Discussions is approved for 2.75 credits livestream AAFP prescribed credits.  

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 2.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 2.75 AAFP Prescribed
  • 2.75 AMA PRA Category 1 Credit
  • 2.75 ANCC
  • 2.75 Attendance

Price

Cost:
$240.00
Please login or register to take this course.

Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.